TAVR is a minimally invasive procedure to replace the aortic valve in patients with severe aortic stenosis. Originally developed for patients who were too ill for open-heart surgical aortic valve replacement (SAVR), TAVR is now approved by FDA in any patients with severe aortic stenosis.
TAVR requires a team of physicians with different expertise, working together during the procedure
Meet the TAVR team at Good Shepherd Hospital
Jeffrey Freihage , Interventional Cardiology
Sarah Johnson , Interventional Cardiology
Tim Votapka , Cardiovascular Surgeon
Irina Staicu , Imaging Cardiologist , 3 D TEE
John Ken Lee , anesthesiology
Patients who undergo the TAVR procedure typically experience less down time, faster recovery and a shorter hospital stay (3 to 5 days on average) than surgical patients
Most TAVR patients regain their strength and are able to begin cardiac rehabilitation within a period of days or weeks. In contrast, open-heart surgical procedures often require up to three months for recovery.
Read more about TAVR